Ophthalmic Eye Dropper Market Outlook:
Ophthalmic Eye Dropper Market size was valued at USD 15.6 billion in 2025 and is expected to reach USD 28.74 billion by 2035, expanding at around 6.3% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of ophthalmic eye dropper is assessed at USD 16.48 billion.
The increasing prevalence of eye disorders such as glaucoma, allergies, conjunctivitis, and dry eye are reflecting a positive influence on ophthalmic eye dropper sales. The change in lifestyles, genetics, poor eating habits, high exposure to UV rays, and increasing stress levels are some of the factors leading to the cause of eye disorders. The most prevalent eye disorder is dry eye, the high exposure to screens is the leading cause of it.
Dry eye cases and vision loss are observed in almost all age groups, youngsters and adults with longer screen time. For instance, according to the Centers for Disease Control and Prevention, dry eye is most prevalent and accounts for 70% to 90% of cases of age-related macular degeneration (AMD). The same source also estimates that around 1.8 million American individuals over 40 years of age are affected by AMD. Additionally, the International Agency for the Prevention of Blindness (IAPB) estimates around 771 million globally are living with vision loss which can be treated, out of which 100 million people have cataracts. The most cases are observed in low- and middle-income countries, around 90% of the total global cases.
Considering these facts, key market players are investing heavily in producing advanced ophthalmic eye care solutions including eye drops. The rising cases of eye disorders are serious healthcare challenges but offer lucrative opportunities for ophthalmic eye dropper manufacturers. For instance, AbbVie Inc’s key product revenues, 12 months ended December 31, 2023 (unaudited) financial report reveals that the total net revenue from the eye care products accounted for USD 2415 million. Furthermore, the total reported change compared to 2022 is 10.6%.
